Back to search
FDAFDA · Food and drugs·Recall number Z-2439-2024

Sensis Vibe systems with software version VD15B in combination with VM VIRTUAL SERVER Model: 10765502-Intended to be used as a diagnostic and administrative tool supporting hemodynamic catheterizations and/or electrophysiology studies, for cardiac as well as interventional Radiology as well as surgical studies. Equipped by modules, enabling various configurations.

Published July 31, 2024 · Recall initiated: July 3, 2024

Summary

FDA records medical device Class II recall Z-2439-2024, published July 31, 2024 and initiated July 3, 2024. Recalling firm: Siemens Medical Solutions USA, Inc; Status: Ongoing; Reported quantity: 7 systems; Lot: UDI-DI: N/A Serial Numbers: Serial 18023 18022 18020 18021 18019 18025 18017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

If the Sensis documentation functionality is used during adding of once-per-study reporting events (e.g., Type 1 events, as further defined in the administrator manual), the possibility exists that the application could crash.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Medical Solutions USA, Inc
Distributor
US Nationwide distribution in the states of CA, CT, FL, IA, KS, MA, MI, NJ, TX, VA.
Lot
UDI-DI: N/A Serial Numbers: Serial 18023 18022 18020 18021 18019 18025 18017
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Sensis Vibe systems with software version VD15B in combination with VM VIRTUAL SERVER Model: 10765502-Intended to be used as a diagnostic and administrative tool supporting hemodynamic catheterizations and/or electrophysiology studies, for cardiac as well as interventional Radiology as well as surgical studies. Equipped by modules, enabling various configurations. recalled?

Yes. FDA published recall Z-2439-2024 on July 31, 2024. Reported hazard: If the Sensis documentation functionality is used during adding of once-per-study reporting events (e.g., Type 1 events, as further defined in the administrator manual), the possibility exists that the application could crash.

What should I do if I have this product?

Voluntary: Firm initiated · Letter